However, the measurement of new biomarkers like NGAL after PCI is allied to several limitations such as varying results and different values for the prediction of contrast-induced AKI.33-37 However, different values of NGAL for AKI prediction have been reported in clinical studies. The gene discussed is LCN2; the disease is acute kidney injury.